Mercaptopurine/Definition: Difference between revisions
Jump to navigation
Jump to search
imported>Howard C. Berkowitz No edit summary |
imported>Howard C. Berkowitz No edit summary |
||
| Line 1: | Line 1: | ||
<noinclude>{{Subpages}}</noinclude> | <noinclude>{{Subpages}}</noinclude> | ||
Antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting [[purine]] metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for [[leukemia]]. | [[Antimetabolite]] antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting [[purine]] metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for [[leukemia]]. | ||
Latest revision as of 20:14, 14 February 2010
This article contains just a definition and optionally other subpages (such as a list of related articles), but no metadata. Create the metadata page if you want to expand this into a full article.
Mercaptopurine [r]: Antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia.